Active, Not Recruiting
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
NCT03580928
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- Stamford Hospital/Bennett Cancer Center Stamford, Connecticut, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Lifespan Cancer Institute Providence, Rhode Island, United States